文献速递临床试验与 GCP流行病学与生物统计

HOPPSA 研究方案更新:子宫切除术中机会性输卵管切除术注册随机对照试验的方案变更

HOPPSA update: changes in the study protocol of Hysterectomy and OPPortunistic SAlpingectomy, a registry-based randomized controlled trial.
PubMed 文献 · Trials · 2023-03-24

HOPPSA 试验是一项多中心全国注册随机对照试验,评估子宫切除术中行机会性输卵管切除术以降低上皮性卵巢癌风险的安全性和有效性。本文报告试验启动以来的方案修订,主要涉及数据分析方法,招募、随机化、干预或主要结局随访未变,2021 年中期分析认为应继续至达到目标样本量。

要点

  • 主要结局并发症将仅基于 GynOp 质量注册中的特定评估,Clavien-Dindo 分级作为次要结局评估。
  • 并发症主要分析采用二项广义估计方程(GEE)对数链接,Miettinen 和 Nurminen 未调整分析作为敏感性分析。
  • 绝经评定量表(MRS)绝对变化主要采用混合效应模型,调整基线 MRS 并以中心为随机效应,术后 3 年也测量 MRS。

核心结论

  • 方案变更主要涉及数据分析;招募、随机化、干预或主要结局随访未做变更。
  • 2021 年中期分析认为研究应继续至达到目标样本量。

研究设计与样本

  • HOPPSA 试验为多中心全国注册随机对照试验,检验子宫切除术中行机会性输卵管切除术降低上皮性卵巢癌风险的安全性和有效性。
  • 研究方案于 2019 年 1 月首次发表,本文报告试验启动以来对方案所做的修订。
  • 试验注册于 ClinicalTrials.gov,编号 NCT03045965,注册日期 2017 年 2 月 8 日。

主要发现

  • 主要结局分析已变更:并发症采用二项广义估计方程(GEE)对数链接分析,Miettinen 和 Nurminen 未调整分析作为敏感性分析。
  • MRS 绝对变化主要采用混合效应模型分析,调整基线 MRS 并以中心为随机效应。
  • 上皮性卵巢癌时间采用混合效应 Cox 回归模型分析并以中心为随机效应,未调整 log-rank 检验作为敏感性分析。
  • 主要结局并发症将仅基于 GynOp 质量注册中的特定评估,Clavien-Dindo 分级作为次要结局评估。
  • MRS 也在术后 3 年测量,以更好确定更年期症状的发生时间。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The HOPPSA trial is a multi-center national registry-based randomized controlled trial to test the safety and effectiveness of performing opportunistic salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer (EOC). The study protocol was first published in January 2019 and is available at https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-3083-8 . Here, we report amendments made to the study protocol since commencement of the trial. CHANGES IN METHODS AND ANALYSIS: The primary outcomes analyses have been changed. (1) Complications will be analyzed using binomial generalized estimating equation (GEE) with log link function, while the unadjusted analyses according to Miettinen and Nurminen will be performed as a sensitivity analysis. (2) Absolute change in Menopause Rating Scale (MRS) will primarily be analyzed using a mixed effects model, adjusted for baseline MRS and center as a random effect. (3) Time to EOC will be analyzed using the mixed effects Cox regression model with center as random effect, while the unadjusted log-rank test will be performed as a sensitivity analysis. The primary outcome Complications will be based solely on the specific assessment in the GynOp quality registry. The Clavien-Dindo classification will be evaluated as a secondary outcome. Furthermore, MRS is also measured three years postoperatively to better pinpoint the onset of menopausal symptoms. DISCUSSION: The changes to the protocol mainly concern the analyses of data. No changes to recruitment, randomization, intervention, or follow-up of primary outcomes have been made. An interim analysis during 2021 concluded that the study should continue until the target sample size is reached. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03045965 . Registered 8 February 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Idahl A, Liv P, Darelius A, et al. HOPPSA update: changes in the study protocol of Hysterectomy and OPPortunistic SAlpingectomy, a registry-based randomized controlled trial. Trials. 2023. PMID: 36959664. doi:10.1186/s13063-023-07244-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。